I have researched and understand the basic principle and approach of a checkerboard titration.
In a recent discussion with my manager, several questions have come up:
These relate specifically to sandwich ELISAs
1. Why would the primary Ab be optimized rather than coating as much of the plate as possible to enhance antigen capture?
My thought is cost and finding the level that capture the antigen at the high end of the linear range, but still conserving Ab. I wonder if non-specific binding affects play a role as well.
2. Why would the secondary Ab be optimized?
Here, I'm pretty sure this is a cost consideration, but confirmation would be appreciated. Or correction if needed.
3. If the antigen of interest is in a complex matrix (such as whole blood or serum), how are non-specific interactions characterized? When developing the ELISA, is a buffer used, or is antigen negative sera spiked with a known amount of antigen?
4. Can anyone explain why the usual starting dilutions series is 1:2? Is there a dilution factor that will likely encompass the dynamic range of most Ab-Ag pairs?
Thank you for any insights into the reasons behind the conventions of checkerboard titrations.